Salary Of A Dentist

Interleukin, U-M School of Dentistry finish enrollment in PST Genetic Test study

The University of Michigan School of Dentistry and Interleukin
Genetics, Inc. (OTCQB: ILIU) announced currently a execution of
studious enrollment for a landmark clinical investigate regulating Interleukin’s PST^®
Genetic Test to establish if dental patients can be risk-stratified
to beam magnitude of surety dental visits and revoke a adverse
outcomes of periodontal illness progression, such as tooth loss.
   

The study, led by William Giannobile, D.D.S., D.Med.Sc., Director of theArticle source: http://www.news-medical.net/news/20120329/Interleukin-U-M-School-of-Dentistry-complete-enrollment-in-PST-Genetic-Test-study.aspx

Tags: advancement, center, Chairman, Classification, completion, consenting adults, corporation, database, dental claims, dental patients, dental visits, Dentistry, Department, director, disease, DNA, enrollment, Frequency, Genetic, genetic test, genetic variations, genetics, health, history, history participants, ILIU, Inc, individual, inflammation, information, Interleukin, interleukin genetics inc, landmark, loss, m school, maintenance, Michigan, michigan center, oral health research, oral medicine, organization, OTCQB, panel, patient, patient enrollment, periodontal health, periodontics, progression, proprietary panel, PST, renaissance, renaissance health, research, risk, risk classification, sample, School, school of dentistry, Service, study, test, Today, Tooth, tooth loss, University, university of michigan school of dentistry